Concord Drugs Share Price

NSE

BSE

CONCORD DRUGS

Sector : Pharmaceuticals and health care | Smallcap | BSE

Here's the live share price of Concord Drugs along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹69.93 Closed

1.35₹ 0.93

As on Sep 16, 2025, 4:01 PM IST

Concord Drugs Price Performance

Today's LowToday's High

₹69.50₹70.37

₹69.93

52 Weeks' Low52 Weeks' High

₹26.10₹71.00

₹69.93

Open Price

₹70.37

Prev. Close

₹69.00

Volume

8,353

Over the last 5 years, the share price of Concord Drugs has gained 31.62% CAGR. Over the past year, the corresponding return has been 86.98%.

Concord Drugs’s current P/E of 164.15x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Breakout Stocks Screener.

Concord Drugs Peer Comparision

Name	1W(%)	1M(%)	3M(%)	6M(%)	1Y(%)	3Y(%)	5Y(%)
Concord Drugs	3.88	37.12	133.49	105.43	86.98	26.99	31.62
Sun Pharmaceutical Industries	0.99	-1.32	-4.43	-5.58	-13.53	22.86	25.44
Divi's Laboratories	1.35	-1.39	-9.09	7.26	10.98	19.38	13.39
Cipla	0.28	-0.53	1.92	4.23	-6.24	14.18	15.63
Torrent Pharmaceuticals	-2.95	-3.25	7.81	15.50	2.38	33.75	19.96
Dr. Reddy's Laboratories	1.32	3.70	-2.69	13.92	-1.44	17.09	7.19
Mankind Pharma	-0.83	3.97	8.45	18.23	4.55	21.72	12.52
Zydus Lifesciences	-0.29	4.77	6.12	15.71	-7.35	42.05	21.62
Lupin	4.71	4.15	2.02	3.02	-8.93	48.04	14.81
Abbott India	1.23	-4.93	-2.02	2.81	6.44	20.90	13.41
Alkem Laboratories	3.35	3.02	13.21	14.40	-13.33	20.01	14.29
Aurobindo Pharma	4.59	0.18	-4.54	-1.88	-30.10	26.95	5.60
Glenmark Pharmaceuticals	-1.88	5.17	23.41	45.12	19.22	77.31	32.95
Laurus Labs	-0.79	3.44	31.66	53.95	77.42	20.10	27.14
Biocon	-1.25	-1.13	0.78	7.85	-7.84	7.35	-3.86
Anthem Biosciences	1.45	3.75	13.75	13.75	13.75	4.39	2.61
GlaxoSmithKline Pharmaceuticals	-2.60	-1.60	-18.46	1.95	-3.00	24.23	9.16
Cohance Lifesciences	-2.90	10.08	-0.45	-12.87	-15.54	28.96	21.52
Gland Pharma	5.31	2.52	14.26	30.13	8.35	-4.11	2.12
Ipca Laboratories	-0.61	-5.32	-3.76	-0.34	-10.15	14.97	3.52

Over the last one year, Concord Drugs has gained 86.98% compared to peers like Sun Pharmaceutical Industries (-13.53%), Divi's Laboratories (10.98%), Cipla (-6.24%). From a 5 year perspective, Concord Drugs has outperformed peers relative to Sun Pharmaceutical Industries (25.44%) and Divi's Laboratories (13.39%).

Concord Drugs Financials

Concord Drugs Stock Technicals

Moving Average

Day	SMA	EMA
5	67.45	68.29
10	65.27	66.25
20	58.91	62.86
50	57.96	56.6
100	44.88	49.83
200	39.84	44.03

Concord Drugs Share Holding Pattern

In the latest quarter, Concord Drugs remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding unchanged at 45.61% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Concord Drugs Corporate Actions

Date Time	Announcement
Sep 09, 2025, 9:46 PM IST	Concord Drugs - Reg. 34 (1) Annual Report.
Sep 09, 2025, 1:58 AM IST	Concord Drugs - Letter To Shareholders
Sep 09, 2025, 1:55 AM IST	Concord Drugs - Annual Report
Sep 09, 2025, 1:50 AM IST	Concord Drugs - Record Date For AGM
Sep 09, 2025, 1:47 AM IST	Concord Drugs - Announcement under Regulation 30 (LODR)-Change in Management

About Concord Drugs

Concord Drugs Ltd. is a Public Limited Listed company incorporated on 24/04/1995 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24230TG1995PLC020093 and registration number is 020093. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 36.93 Cr. and Equity Capital is Rs. 10.00 Cr. for the Year ended 31/03/2025.

Industry
Pharmaceuticals
Address
Survey No.249, R R District Telangana 501511
Contact
concorddrugsltd@gmail.com http://www.concorddrugs.in

Management

Mr. S Nagi Reddy
Chairman & Managing Director
Mr. S Manoj Kumar Reddy
Whole Time Director
Mr. S Koni Reddy
WholeTime Director & CFO
Mr. K Ramachandra Reddy
Independent Director
Ms. Sumeela Kasu
Independent Director
Mr. S Nagavenkata Hareesh
Independent Director

FAQs on Concord Drugs Share Price

What is the share price of Concord Drugs?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Concord Drugs is ₹69.93 as on Sep 16, 2025.

What kind of stock is Concord Drugs?

The Concord Drugs is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.

What is the Market Cap of Concord Drugs?

The market cap of Concord Drugs is ₹69.93 Cr as on Sep 16, 2025.

What are today's High and Low prices of Concord Drugs?

Today’s highest and lowest price of Concord Drugs are ₹70.37 and ₹69.50.

What are the 52 Week High and 52 Week Low of Concord Drugs?

The 52-week high/low is the highest and lowest price at which Concord Drugs stock has traded in the past 52-week or nearly a year. The 52-week high of Concord Drugs is ₹71.00 and 52-week low of Concord Drugs is ₹26.10 as on Sep 16, 2025.

How has the Concord Drugs performed historically in terms of returns?

The Concord Drugs has shown returns of 1.35% over the past day, 37.12% for the past month, 133.49% over 3 months, 86.98% over 1 year, 26.99% across 3 years, and 31.62% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Concord Drugs?

P/E ratio of and PB ratio of Concord Drugs are 164.15 and 2.06 on Sep 16, 2025. While the company gives a dividend yield of 0.00 per annum.

Market Data

1 Day	1.35%
1 Month	37.12%
3 Months	133.49%
YTD	84.22%
1 Year	86.98%
3 Years	26.99%
5 Years	31.62%
10 Years	3.82%

Face Value (Rs) 10.00	EPS-TTM (Rs) 0.43	Dividend/Share (Rs) 0
PE Ratio (x) 164.15	PB Ratio (x) 2.06	EV/EBITDA (x) 11.58
Div. Yield (%) 0	Beta (1M) 0.42